Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

20 June 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Momenta Pharmaceuticals Articles

News briefs: Copaxone patent ruling; German Sativex backing; Depomed licenses Zipsor

24 June 2012

Future for biosimilars hugely promising, Momenta CEO tells GPhA meeting

26 February 2012

Watson settles over Exalgo; gets favorable news on enoxaparin

29 January 2012

Baxter taps Momenta expertise on biosimilars

28 December 2011

Watson temporarily restrained from marketing generic Lovenox; challenges Pfizer’s Embeda patent

10 October 2011

Teva prevails in Copaxone law suit with Mylan/Natco and Sandoz/Momenta

30 August 2011

US Supreme Court agrees to hear generic drug labelling case; Teva files to stop generic Copaxone

13 December 2010

Momenta Pharma sues Teva for enoxaparin patent infringement

3 December 2010

Showing 1-8 of 8 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
  • Negative US patent ruling for Novo Nordisk on Prandin
  • Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • Daiichi Sankyo files for Japanese approval of Prasugrel
  • FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
  • Negative US patent ruling for Novo Nordisk on Prandin
  • Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
  • US Supreme Court says patent settlement can "sometimes" be illegal
  • Daiichi Sankyo files for Japanese approval of Prasugrel

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS